ID   HX156c
AC   CVCL_L443
SY   HX156; HX/156; HX/156c
DR   IARC_TP53; 21693
DR   Wikidata; Q54896983
RX   PubMed=2441858;
RX   PubMed=2475347;
RX   PubMed=7751322;
RX   PubMed=8347478;
RX   PubMed=9887230;
RX   PubMed=35692560;
CC   Doubling time: 30 hours (Note=At 75th passage) (PubMed=2441858).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
RX   PubMed=2441858;
RA   Kelland L.R., Burgess L., Steel G.G.;
RT   "Characterization of four new cell lines derived from human squamous
RT   carcinomas of the uterine cervix.";
RL   Cancer Res. 47:4947-4952(1987).
//
RX   PubMed=2475347; DOI=10.1016/0277-5379(89)90417-3;
RA   Kelland L.R., Tonkin K.S.;
RT   "In vitro chemosensitivity of four new carcinoma of the cervix cell
RT   lines: relationship to radiosensitivity.";
RL   Eur. J. Cancer Clin. Oncol. 25:1211-1218(1989).
//
RX   PubMed=7751322; DOI=10.1007/BF01366967;
RA   Rantanen V., Grenman S.E., Kulmala J., Grenman R.;
RT   "The intrinsic radiosensitivity and sublethal damage repair capacity
RT   of five cervical carcinoma cell lines tested with the 96-well-plate
RT   assay.";
RL   J. Cancer Res. Clin. Oncol. 121:230-234(1995).
//
RX   PubMed=8347478; DOI=10.1038/bjc.1993.322; PMCID=PMC1968570;
RA   Mellish K.J., Kelland L.R., Harrap K.R.;
RT   "In vitro platinum drug chemosensitivity of human cervical squamous
RT   cell carcinoma cell lines with intrinsic and acquired resistance to
RT   cisplatin.";
RL   Br. J. Cancer 68:240-250(1993).
//
RX   PubMed=9887230; DOI=10.1006/gyno.1998.5194;
RA   Rantanen V., Grenman S.E., Kurvinen K., Hietanen S.H., Raitanen M.,
RA   Syrjanen S.M.;
RT   "p53 mutations and presence of HPV DNA do not correlate with
RT   radiosensitivity of gynecological cancer cell lines.";
RL   Gynecol. Oncol. 71:352-358(1998).
//
RX   PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225;
RA   de Lourdes Zuniga-Martinez M., Lopez-Mendoza C.M., Tenorio-Salazar J.,
RA   Garcia-Carranca A.M., Cerbon-Cervantes M.A., Alcantara-Quintana L.E.;
RT   "Establishment, authenticity, and characterization of cervical cancer
RT   cell lines.";
RL   Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022).
//